[title] | [date] | [link] | [market] | [doc type] | [stock code] | [stock name] |
Next Day Disclosure Returns | 14/12/2021 21:32 | Link | SEHK | 01681 | CONSUN PHARMA | |
APPOINTMENT AND RESIGNATION OF EXECUTIVE DIRECTOR | 14/12/2021 21:28 | Link | SEHK | 00381 | KIU HUNG INT'L | |
Voluntary and Business Update Announcement Achieving Collaboration with OVMEDI for the Embedding Thread Product | 14/12/2021 21:16 | Link | SEHK | 00867 | CMS | |
CONTINUING CONNECTED TRANSACTIONS THE FRAMEWORK AGREEMENT | 14/12/2021 21:09 | Link | SEHK | 03773 | NNK | |
CONNECTED TRANSACTIONS 2022 OFFICE LEASE AGREEMENTS | 14/12/2021 21:08 | Link | SEHK | 01755 | S-ENJOY SERVICE | |
Net Asset Value | 14/12/2021 21:06 | Link | SEHK | 00721 | C FIN INT INV | |
VOLUNTARY ANNOUNCEMENT - INCREASE IN SHAREHOLDING BY A CONTROLLING SHAREHOLDER | 14/12/2021 20:54 | Link | SEHK | 01745 | LVJI TECH | |
(1) CHANGE OF CHIEF FINANCIAL OFFICER; AND (2) CHANGE OF COMPANY SECRETARY AND AUTHORISED REPRESENTATIVES | 14/12/2021 20:52 | Link | SEHK | 06611 | SANXUN GROUP | |
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section | 14/12/2021 20:42 | Link | SEHK | htm | 01839 | CIMC VEHICLES |
SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO DISCLOSEABLE TRANSACTION ACQUISITION OF EQUITY INTERESTS IN CH-AUTO TECHNOLOGY | 14/12/2021 20:37 | Link | SEHK | 00527 | RUIFENG RENEW | |
US$250,000,000 4.5% Notes Due September 2023 - Purchase and Cancellation of Part of the Notes | 14/12/2021 20:32 | Link | SEHK | 00163 | EMPEROR INT'L | |
ANNOUNCEMENT ON THE RECEIPT OF "CIVIL MEDIATION DOCUMENT" BY BEIJING TAINHAI CRYOGENIC EQUIPMENT CO., LTD. | 14/12/2021 20:29 | Link | SEHK | 00187 | JINGCHENG MAC | |
List of Directors and Their Roles and Functions | 14/12/2021 20:27 | Link | SEHK | 03808 | SINOTRUK | |
CHANGES OF NON-EXECUTIVE DIRECTORS | 14/12/2021 20:23 | Link | SEHK | 03808 | SINOTRUK | |
CHANGE OF ADDRESS OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG | 14/12/2021 20:19 | Link | SEHK | 02175 | CH GENERAL EDU | |
Grant of Share Options | 14/12/2021 20:15 | Link | SEHK | 00210 | DAPHNE INT'L | |
Voluntary Announcement - Ascentage Pharma Presents Results of Six Studies of Three Novel Drug Candidates under Development (Olverembatinib, APG-2575, and APG-1252) at the 63rd American Society of Hematology (ASH) Annual Meeting | 14/12/2021 20:08 | Link | SEHK | 06855 | ASCENTAGE-B | |
SUPPLEMENTAL ANNOUNCEMENT TO DISCLOSEABLE TRANSACTION IN RELATION TO THE FORMATION OF PROJECT COMPANY UNDER THE COOPERATION FRAMEWORK AGREEMENT | 14/12/2021 20:02 | Link | SEHK | 03728 | CHING LEE | |
GRANT OF RSU PURSUANT TO THE 2021 RSU SCHEME | 14/12/2021 20:02 | Link | SEHK | 01739 | QEEKA HOME | |
DELAY IN DESPATCH OF CIRCULAR IN RELATION TO (I) PROPOSED RIGHTS ISSUE ON THE BASIS OF TWO RIGHTS SHARES FOR EVERY ONE EXISTING SHARE HELD ON THE RECORD DATE; (II) CONNECTED TRANSACTIONS IN RELATION TO THE UNDERWRITING AGREEMENT AND SET OFF OF SHAREHOLDER'S LOANS; (III) APPLICATION FOR WHITEWASH WAIVER; AND (IV) NOTICE OF EXTRAORDINARY GENERAL MEETING | 14/12/2021 20:02 | Link | SEHK | 02363 | TONGDA HONG TAI |
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Consun Pharmaceutical Group Ltd. published this content on 14 December 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 December 2021 13:37:02 UTC.